CN118045010A - 一种含有植物复方精油组合物的保湿修复精华油及其制备方法 - Google Patents
一种含有植物复方精油组合物的保湿修复精华油及其制备方法 Download PDFInfo
- Publication number
- CN118045010A CN118045010A CN202410136572.6A CN202410136572A CN118045010A CN 118045010 A CN118045010 A CN 118045010A CN 202410136572 A CN202410136572 A CN 202410136572A CN 118045010 A CN118045010 A CN 118045010A
- Authority
- CN
- China
- Prior art keywords
- oil
- seed oil
- parts
- tocopherol
- essential oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 78
- 239000000341 volatile oil Substances 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims description 16
- 239000003921 oil Substances 0.000 claims abstract description 82
- 235000019198 oils Nutrition 0.000 claims abstract description 82
- 241000196324 Embryophyta Species 0.000 claims abstract description 41
- 239000002537 cosmetic Substances 0.000 claims abstract description 31
- 235000020235 chia seed Nutrition 0.000 claims abstract description 28
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 25
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 25
- 230000000694 effects Effects 0.000 claims abstract description 11
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 84
- 239000011732 tocopherol Substances 0.000 claims description 35
- 229930003799 tocopherol Natural products 0.000 claims description 35
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 31
- 235000010384 tocopherol Nutrition 0.000 claims description 31
- 229960001295 tocopherol Drugs 0.000 claims description 31
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 31
- 235000001498 Salvia hispanica Nutrition 0.000 claims description 28
- 240000005481 Salvia hispanica Species 0.000 claims description 28
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 27
- 235000001500 Salvia lavandulifolia Nutrition 0.000 claims description 25
- 244000258095 Salvia lavandulifolia Species 0.000 claims description 25
- 235000006708 antioxidants Nutrition 0.000 claims description 24
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 23
- 239000002904 solvent Substances 0.000 claims description 21
- 240000000513 Santalum album Species 0.000 claims description 17
- 235000008632 Santalum album Nutrition 0.000 claims description 17
- 230000008439 repair process Effects 0.000 claims description 17
- 244000197813 Camelina sativa Species 0.000 claims description 15
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 14
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 14
- 240000005385 Jasminum sambac Species 0.000 claims description 14
- 244000042664 Matricaria chamomilla Species 0.000 claims description 14
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 14
- 235000007769 Vetiveria zizanioides Nutrition 0.000 claims description 14
- 244000284012 Vetiveria zizanioides Species 0.000 claims description 14
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 13
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 13
- 229940036350 bisabolol Drugs 0.000 claims description 13
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 13
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 13
- 229940032094 squalane Drugs 0.000 claims description 13
- 235000014595 Camelina sativa Nutrition 0.000 claims description 12
- 240000001548 Camellia japonica Species 0.000 claims description 12
- 244000020551 Helianthus annuus Species 0.000 claims description 12
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 11
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 238000005303 weighing Methods 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 10
- 229960002446 octanoic acid Drugs 0.000 claims description 10
- 240000007817 Olea europaea Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 244000003027 Bergamotto Species 0.000 claims description 7
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 7
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 7
- 235000007457 Jasminum sambac Nutrition 0.000 claims description 7
- 244000179970 Monarda didyma Species 0.000 claims description 7
- 235000010672 Monarda didyma Nutrition 0.000 claims description 7
- 241000220317 Rosa Species 0.000 claims description 7
- 235000000659 Rosa rugosa Nutrition 0.000 claims description 7
- 240000006066 Rosa rugosa Species 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 7
- 230000001804 emulsifying effect Effects 0.000 claims description 7
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 7
- 235000003320 Adansonia digitata Nutrition 0.000 claims description 6
- 244000056974 Adansonia digitata Species 0.000 claims description 6
- 244000144725 Amygdalus communis Species 0.000 claims description 6
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 6
- 235000007689 Borago officinalis Nutrition 0.000 claims description 6
- 240000004355 Borago officinalis Species 0.000 claims description 6
- 235000006467 Camellia japonica Nutrition 0.000 claims description 6
- 241000282693 Cercopithecidae Species 0.000 claims description 6
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 6
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 6
- 244000298479 Cichorium intybus Species 0.000 claims description 6
- 235000011309 Crambe hispanica subsp abyssinica Nutrition 0.000 claims description 6
- 241000220247 Crambe hispanica subsp. abyssinica Species 0.000 claims description 6
- 235000017011 Mandorlo dulce Nutrition 0.000 claims description 6
- 244000076313 Mandorlo dulce Species 0.000 claims description 6
- 235000006801 Ximenia americana Nutrition 0.000 claims description 6
- 244000112726 Ximenia americana Species 0.000 claims description 6
- 235000018597 common camellia Nutrition 0.000 claims description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 6
- PXBPXLOPWHUDGF-UHFFFAOYSA-N 7,8,8-trihexylhexadecan-7-ol Chemical compound C(CCCCC)C(C(O)(CCCCCC)CCCCCC)(CCCCCCCC)CCCCCC PXBPXLOPWHUDGF-UHFFFAOYSA-N 0.000 claims description 5
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 5
- 229940072107 ascorbate Drugs 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 235000013793 astaxanthin Nutrition 0.000 claims description 5
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 5
- 229940022405 astaxanthin Drugs 0.000 claims description 5
- 239000001168 astaxanthin Substances 0.000 claims description 5
- 238000009924 canning Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 229940042585 tocopherol acetate Drugs 0.000 claims description 4
- 235000019149 tocopherols Nutrition 0.000 claims description 4
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims description 4
- 235000016401 Camelina Nutrition 0.000 claims description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 3
- 241000237501 Crassostrea Species 0.000 claims description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 3
- 235000002725 Olea europaea Nutrition 0.000 claims description 3
- 102100029469 WD repeat and HMG-box DNA-binding protein 1 Human genes 0.000 claims description 3
- 101710097421 WD repeat and HMG-box DNA-binding protein 1 Proteins 0.000 claims description 3
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 claims description 3
- 229960000271 arbutin Drugs 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 3
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000002020 sage Nutrition 0.000 claims description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 2
- 125000002138 bisabolol group Chemical group 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 230000008591 skin barrier function Effects 0.000 abstract description 17
- 239000000463 material Substances 0.000 abstract description 6
- 230000007794 irritation Effects 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000013329 compounding Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 50
- 239000000523 sample Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 12
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000012224 working solution Substances 0.000 description 8
- 239000002158 endotoxin Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 210000002510 keratinocyte Anatomy 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 101100238555 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) msbA gene Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000036620 skin dryness Effects 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000037075 skin appearance Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000197194 Bulla Species 0.000 description 1
- 101100017018 Caenorhabditis elegans him-14 gene Proteins 0.000 description 1
- 101100292209 Caenorhabditis elegans msh-5 gene Proteins 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 description 1
- 102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 description 1
- 101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 description 1
- 101100238612 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) msh-3 gene Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000212749 Zesius chrysomallus Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种植物复方精油组合物，以及植物复方精油组合物在制备保湿修复化妆品中的应用。通过将奇亚籽油与抗氧化剂复配为复合奇亚籽油，大大提升了奇亚籽油的稳定性，并进一步提升了整个植物复方精油体系的稳定性。同时添加复合微量精油与皮肤调理剂，显著增强了植物复方精油的保湿、修复功效。并且通过合理搭配各成分及其用量，使得产品在少含或不含化学合成辅料的情况下，仍能保持产品整体优异的保质期与稳定性，降低了产品整体的刺激性，更适宜皮肤屏障受损的消费者使用。
Description
技术领域
本发明属于日用化妆品领域，尤其涉及一种含有植物复方精油组合物的保湿修复精华油及其制备方法，以及植物复方精油组合物在制备化妆品中的应用。
背景技术
皮肤屏障是指皮肤表面的一层保护结构，它由皮脂膜、角质层、微生物层等组成，能够防止水分流失，抵御外界刺激和病菌入侵，维持皮肤的健康和稳定。皮肤屏障受损是指这一保护结构被破坏或削弱，导致皮肤出现干燥、敏感、红血丝、痘痘、色斑等问题。
导致皮肤屏障受损的原因有很多，比如过度清洁、去角质、使用不合适的护肤品、暴露在紫外线或污染环境中等。修复皮肤屏障通常通过以下途径：①停止破坏皮肤屏障，避免使用刺激性或功效性强的护肤品，选择温和、低敏的产品；②舒缓敏感、修复屏障，使用含有修复因子的护肤品，为皮肤构建滋润的修复环境；③严格防护、避免二次伤害，做好防晒工作，减少外出时间，避免接触刺激性物质。
皮肤干燥是指皮肤缺乏水分，导致外观和触感粗糙、发痒、呈片状或鳞状的现象。皮肤干燥的原因有很多，比如天气寒冷或干燥、晒伤、刺激性肥皂和洗浴过度、年龄增长、内分泌失调、某些皮肤病或药物等。皮肤干燥可以通过保湿、防晒、适当饮水、使用温和的洗涤剂、改善饮食和睡眠等方式来预防和改善。
植物复方精油是指由多种植物精油混合而成的一种天然植物提取物，它具有芳香疗法和护肤的双重功效。植物复方精油可以补充皮肤屏障中的细胞间脂质，尤其是亚油酸，对于维持皮肤屏障的完整性和功能至关重要。植物复方精油可以提高皮肤的抗氧化能力，抵抗自由基的损伤，延缓皮肤的老化过程。许多植物精油含有丰富的抗氧化物质，它们可以保护皮肤免受紫外线、污染、炎症等因素的伤害。植物复方精油可以抑制皮肤的炎症反应，减轻皮肤的红肿、瘙痒、刺激等症状。植物精油具有抗菌、抗病毒、抗真菌、抗过敏等作用，可以调节皮肤的免疫系统，平衡皮肤的微生态，防止皮肤屏障的破坏和感染。植物复方精油可以为皮肤提供水分和营养，增加皮肤的水分含量，改善皮肤的干燥和粗糙。植物复方精油中的水溶性成分可以与水结合，形成保湿层，防止水分蒸发；植物复方精油中的油溶性成分可以渗透到皮肤深层，滋润和修复皮肤细胞。植物复方精油可以调节皮肤的油水平衡，适合各种肤质使用。植物复方精油中的单方精油可以根据皮肤的需要，选择不同的功效和香气，达到平衡油脂分泌，控制痘痘，缩小毛孔，提亮肤色等效果。
总之，植物复方精油是一种天然、安全、有效的修复与保湿剂，它可以从内而外地改善皮肤的水分状况和健康状况。
目前已有的修复、保湿类化妆品中，除了各种起修复作用的功效成分外，还添加有多种化学合成的辅料。这些辅料虽然对产品整体的保质期、稳定性等有作用，但对于皮肤屏障已经受损的使用者来说，化学合成的辅料存在刺激性，整体使用感差。因此，开发含有天然植物油脂，少含或不含化学合成辅料的化妆品，已成为当下化妆品领域的研发热点。
发明概述
为了解决现有技术中存在的问题，本发明提供了一种植物复方精油组合物，以及植物复方精油组合物在制备保湿修复化妆品中的应用。
对此，本发明采用以下技术方案：
第一方面，本发明涉及一种植物复方精油组合物，其特征在于，所述植物复方精油组合物包含以下成分：
其中，所述复合奇亚籽油由西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂组成；
所述抗氧化剂选自生育酚、生育酚乙酸酯、生育酚磷酸酯、四己基癸醇抗坏血酸酯或虾青素中的一种或多种；
所述西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂的质量比为(99.9:0.1)～(99.99:0.01)；
所述复合微量精油包含以下成分：
进一步地，所述植物复方精油组合物包含以下成分：
其中，所述复合奇亚籽油由西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂组成；
所述抗氧化剂选自生育酚、生育酚乙酸酯、生育酚磷酸酯、四己基癸醇抗坏血酸酯或虾青素中的任一种；
所述西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂的质量比为(99.93:0.07)～(99.97:0.03)；
所述复合微量精油包含以下成分：
更进一步地，所述植物复方精油组合物由以下成分组成：
其中，所述复合奇亚籽油由西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂组成；
所述抗氧化剂选自生育酚、生育酚乙酸酯或生育酚磷酸酯中的任一种；
所述西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂的质量比为99.95:0.05；
所述复合微量精油由以下成分组成：
第二方面，本发明涉及一种保湿修复化妆品组合物，其特征在于，所述保湿修复化妆品组合物，包含以下成分：
前述第一方面任一所述的植物复方精油组合物 50-60份
油性溶剂 35-50份
皮肤调理剂 0.5-2份；
其中，所述油性溶剂选自椰子油、角鲨烷、辛酸/癸酸甘油三酯或碳酸二辛酯中的一种或多种；所述皮肤调理剂选自红没药醇、熊果苷、烟酰胺、甘草酸二钾或生育酚中的一种或多种。
进一步地，所述保湿修复化妆品组合物，由以下成分组成：
前述第一方面任一所述的植物复方精油组合物 50-60份
油性溶剂 35-50份
皮肤调理剂 0.5-2份；
其中，所述油性溶剂为角鲨烷和辛酸/癸酸甘油三酯，所述角鲨烷和辛酸/癸酸甘油三酯的质量比为(30:10)～(35:12)；所述皮肤调理剂为红没药醇和生育酚，所述红没药醇和生育酚的质量比为(0.08:0.5)～(0.25:1)。
更进一步地，所述保湿修复化妆品组合物，由以下成分组成：
其中，所述复合奇亚籽油由西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚组成；所述西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂的质量比为99.95:0.05；所述复合微量精油由以下成分组成：
更进一步地，所述保湿修复化妆品组合物，由以下成分组成：
第三方面，本发明涉及一种保湿修复化妆品组合物的制备方法，其特征在于，采用如下方法制备：
①按照前述第二方面任一所述的保湿修复化妆品组合物的原料配比，称取组成复合奇亚籽油的西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚；
②将称取好的西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚导入乳化锅中搅拌均匀，制得复合奇亚籽油；
③按照权利要求4-7任一项所述的保湿修复化妆品组合物的原料配比，称取剩余原料；
④将称取好的剩余原料与制备好的复合奇亚籽油，导入乳化锅中搅拌均匀；
⑤静置12小时，罐装；
进一步地，所述的保湿修复化妆品组合物的制备方法，其特征在于，采用如下方法制备：
①称取西班牙鼠尾草(SALVIA HISPANICA)籽油2.49875份和生育酚0.00125份；
②将西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚导入乳化锅中搅拌均匀，制得复合奇亚籽油2.5份；
③称取山茶(CAMELLIA JAPONICA)籽油30份、甜扁桃(PRUNUS AMYGDALUS DULCIS)油10份、深海两节荠(CRAMBE ABYSSINICA)籽油3.6份、亚麻荠(CAMELINA SATIVA)籽油2.5份、玻璃苣(BORAGO OFFICINALIS)籽油2.5份、向日葵(HELIANTHUS ANNUUS)籽油1份、油橄榄(OLEA EUROPAEA)果油1份、猴面包树(ADANSONIA DIGITATA)籽油1份、海檀木(XIMENIAAMERICANA)籽油1份、岩兰草(VETIVERIA ZIZANIOIDES)根油0.1份、檀香(SANTALUM ALBUM)油0.1份、茉莉花(JASMINUM SAMBAC)花油0.1份、香柠檬(CITRUS AURANTIUM BERGAMIA)果油0.1份、玫瑰(ROSA RUGOSA)花油0.03份、母菊(CHAMOMILLA RECUTITA)花油0.01份、沙棘(HIPPOPHAE RHAMNOIDES)果油0.025份、角鲨烷33份、辛酸/癸酸甘油三酯10.34份、红没药醇0.2份和生育酚1份；
④将称取好的山茶(CAMELLIA JAPONICA)籽油30份、甜扁桃(PRUNUSAMYGDALUSDULCIS)油10份、深海两节荠(CRAMBE ABYSSINICA)籽油3.6份、亚麻荠(CAMELINASATIVA)籽油2.5份、玻璃苣(BORAGO OFFICINALIS)籽油2.5份、向日葵(HELIANTHUSANNUUS)籽油1份、油橄榄(OLEA EUROPAEA)果油1份、猴面包树(ADANSONIA DIGITATA)籽油1份、海檀木(XIMENIA AMERICANA)籽油1份、岩兰草(VETIVERIA ZIZANIOIDES)根油0.1份、檀香(SANTALUM ALBUM)油0.1份、茉莉花(JASMINUM SAMBAC)花油0.1份、香柠檬(CITRUSAURANTIUM BERGAMIA)果油0.1份、玫瑰(ROSA RUGOSA)花油0.03份、母菊(CHAMOMILLARECUTITA)花油0.01份、沙棘(HIPPOPHAE RHAMNOIDES)果油0.025份、角鲨烷33份、辛酸/癸酸甘油三酯10.34份、红没药醇0.2份、生育酚1份与搅拌好的复合奇亚籽油2.5份，导入乳化锅中搅拌均匀；
⑤静置12小时，罐装。
第四方面，本发明涉及前述第一方面任一所述的植物复方精油组合物、或前述第二方面任一所述的保湿修复化妆品组合物、或前述第三方面任一所述的制备方法制得的保湿修复化妆品组合物在制备具有保湿、修复功效的化妆品中的应用。
本发明相对于现有技术，具有如下的优点及有益效果：
本发明通过将奇亚籽油与抗氧化剂复配为复合奇亚籽油，大大提升了奇亚籽油的稳定性，并进一步提升了整个植物复方精油体系的稳定性。同时添加复合微量精油与皮肤调理剂，显著增强了植物复方精油的保湿、修复功效。并且通过合理搭配各成分及其用量，使得产品在少含或不含化学合成辅料的情况下，仍能保持产品整体优异的保质期与稳定性，降低了产品整体的刺激性，更适宜皮肤屏障受损的消费者使用。
附图说明
图1.不同皮肤调理剂抑制NO释放能力
图2.不同复合微量精油细胞增殖能力
图3.不同产品对皮肤屏障修复能力
具体实施方式
下面结合具体实施例，进一步阐述本发明。应理解，这些实施例仅用于说明本发明而不用于限制本发明的范围。以下实施例中所用的原料、试剂或装置如无特殊说明，均可从常规商业途径得到，或者可以通过现有已知方法得到。未注明具体条件的实验方法，通常按照常规条件，或按照制造厂商所建议的条件。除非另外说明，否则份数和百分比为重量份和重量百分比。
本文所用缩写具有以下含义：
SH：西班牙鼠尾草(SALVIA HISPANICA)籽油
VE：生育酚
VE-A：生育酚乙酸酯
VE-P：生育酚磷酸酯
VC-IP：四己基癸醇抗坏血酸酯
AST：虾青素
MSH：复合物奇亚籽油
CO：椰子油
SQL：角鲨烷
GTCC：辛酸/癸酸甘油三酯
DIC：碳酸二辛酯
OS：油性溶剂
BSB：红没药醇
ARB：熊果苷
VB3：烟酰胺
DPG：甘草酸二钾
SC：皮肤调理剂
VZ：岩兰草(VETIVERIA ZIZANIOIDES)根油
SA：檀香(SANTALUM ALBUM)油
JS：茉莉花(JASMINUM SAMBAC)花油
CAB：香柠檬(CITRUS AURANTIUM BERGAMIA)果油
RR：玫瑰(ROSA RUGOSA)花油
CR：母菊(CHAMOMILLA RECUTITA)花油
HR：沙棘(HIPPOPHAE RHAMNOIDES)果油
MEO：复合微量精油
实施例一复合奇亚籽油的制备
按照表1所列组成配比称取相应原料，制备复合奇亚籽油MSH-1至MSH-15，各复合奇亚籽油的总重量为3g。
表1不同复合奇亚籽油的组成配比
奇亚籽油[西班牙鼠尾草(SALVIA HISPANICA)籽油]中含有高比例的α-亚麻酸，是一种多不饱和脂肪酸，容易受到氧化的影响，导致油脂变质，对保存条件要求较高。本发明通过将奇亚籽油与合适的抗氧化剂复配使用，在不影响奇亚籽油功效与使用感受的情况下，显著提升了奇亚籽油在常规保存条件下的稳定性。
实验例1.稳定性测试
样品测定：将制备得到的MSH-1至MSH-15以及纯SH分别储存在50℃、4℃、室温(25℃)、阳光直射2个月的条件下，观察其外观。
结果表明：SH在50℃、阳光直射及室温条件下液体变浑浊。添加VE-A的MSH-2、MSH-7、MSH-12和添加VC-IP的MSH-4、MSH-9、MSH-14在50℃条件下液体变浑浊。添加VE-P的MSH-3、MSH-8、MSH-13在阳光直射条件下液体变浑浊。添加AST的MSH-5、MSH-10、MSH-15在50℃、阳光直射及室温条件下液体变浑浊。添加VE的MSH-1、MSH-6在50℃、阳光直射及室温条件下液体均澄清、稳定，未发生浑浊、变质，添加VE的MSH-11在阳光直射条件下产生少许沉淀，其他条件下液体澄清、稳定，未发生浑浊、变质。
由上述实验结果可知，SH中添加质量比为0.05和0.1的VE，复配制成MSH，能够有效防止SH发生变质。综合产品成本角度考量，选择0.05VE/99.95SH复配为MSH。
实施例二油性溶剂的制备
按照表2所列组成配比称取相应原料，制备油性溶剂，各油性溶剂的总重量为10g。
表2不同油性溶剂的组成配比
实验例2.安全性试验
样品测定：将OS-1至OS-12各样油性溶剂浸湿4层1cm2大小的纱布，置前臂屈侧，其上用较纱布稍大的透明玻璃纸覆盖，四周用橡皮膏固定，经48小时取下，查看诱发局部皮肤出现的反应，于48小时、72小时分别根据局部皮肤表现判读个基质样品的安全性结果。
测试油性溶剂OS-1至OS-12的安全性，斑贴试验皮肤不良反应分级标准如表3所示。
表3斑贴试验皮肤不良反应分级标准
| 皮肤不良反应 | 分级 |
| 无反应 | 0 |
| 淡红斑 | 1 |
| 红斑、浸润、丘疹 | 2 |
| 红斑、水肿、丘疹、水疱 | 3 |
| 红斑、水肿、大疱 | 4 |
结果显示，经48小时和72小时试验，油性溶剂OS-5的局部皮肤与未测试皮肤相比并未出现淡红斑敏，红肿等现象，油性溶剂OS-5的分级均为0级。油性溶剂OS-4、OS-6的局部皮肤出现轻微淡红斑，分级为1级。油性溶剂OS-1至OS-3、OS-7至OS12的局部皮肤出现红斑、间或出现轻微丘疹，分级为2。
由上述实验结果可知，质量比为33:10.34的SQL/GTCC复配而成的油性溶剂，对皮肤刺激性最小，不会引皮肤过敏，安全性更好，适用于皮肤屏障受损的人群。
实施例三皮肤调理剂的制备
按照表4所列组成配比称取相应原料，制备皮肤调理剂，各皮肤调理剂的总重量为100mg。
表4不同皮肤调理剂的组成配比
实验例3.不同配比的皮肤调理剂对LPS诱导RAW264.7细胞释放NO抑制作用
本实验利用LPS(脂多糖)诱导RAW264.7细胞产生过敏反应，释放NO(一氧化氮)。NO抑制能力强弱可反映样品的抗炎能力大小。
实验方法：
(1)样品制备
制备1μg/mL的LPS PBS溶液作为阳性对照工作液。将上述制备好的皮肤调理剂组合物SC-1至SC-13各称取10mg，溶于100mL阳性对照工作液中，制备为10％的待测样品工作液。
(2)细胞培养
将RAW264.7细胞接种到96孔板中，每一孔为100μl，5×103cells/孔。
在37℃，5％CO2的培养箱中培养24小时。
(3)样品检测
细胞培养24小时后，移除培养基，并PBS洗涤。洗涤后每孔加入90μl培养基+10μl待测样品工作液或阳性对照工作液(保持每孔待测样品终浓度为1％，LPS终浓度为0.1μg/mL)。
样品加入之后，放入37℃，5％CO2的培养箱中培养20小时。20小时后，移取50μl的培养基到新的96孔板上，加入50μl 1％的Griessr试剂，混合后于暗处反应10分钟。酶标仪在540nm处测试样品的吸光光度值，平行重复3次。
NO抑制率％＝(ALPS-ABJ)/ALPS×100％
其中：ALPS表示阳性对照样品吸光度，ASC各测试样品吸光度。
实验结果如图1所示。
结论：BSB与VE按0.2:1的比例复配为组合物时，抗炎效果最佳，且优于单种皮肤调理剂与其他皮肤调理剂组合物。
实施例四复合微量精油的制备
按照表5所列组成配比称取相应原料，制备复合微量精油。
表5不同植物组合物的组成配比
实验例4.不同配比的复合微量精油对角质形成细胞的增殖作用
本实验通过评估不同复合微量精油对角质形成细胞的增殖作用，反映样品的修复能力大小。
实验方法：
(1)样品制备
将上述制备好的复合微量精油MEO-1至MEO11各称取4.65mg，溶于996.4mg实施例二制得的OS-5油性溶剂中，制备为精油样品溶液，再各取精油样品溶液1μL，分散于9μL细胞培养级DMSO中，制得待测样品工作液。
(2)细胞培养
将人永生化角质形成(HaCaT)细胞接种到96孔板中，每一孔为100μl，5×103cells/孔。
在37℃，5％CO2的培养箱中培养24小时。
(3)样品检测
1)加药干预：待细胞完全贴壁生长后，更换新鲜培养基，每孔100μL，以待测样品工作液进行加药处理，1μL待测样品工作液/孔，同时以1μL PBS/孔处理作为对照组，设置3个复孔，放回细胞培养箱中继续培养。
2)CCK-8测定：加药干预24小时后吸移原培养基，以含10％ CCK-8的培养基进行换液处理，每孔100μL。混匀后继续孵育1小时。
3)酶标仪450nm波长条件下进行吸光度测定。细胞存活率(％)＝待测样品组OD值/对照组OD值×100％。
实验结果如图2所示。
结论：MEO-8复合微量精油能够有效促进角质细胞增殖，MEO-1至MEO-7各单独精油基本无促进角质细胞增殖的功效，MEO-9至MEO-11复合微量精油促进角质细胞增殖效果不显著。
实施例五一种保湿修复化妆品的制备
①称取西班牙鼠尾草(SALVIA HISPANICA)籽油2.49875份和生育酚0.00125份；
②将西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚导入乳化锅中搅拌均匀，制得复合奇亚籽油2.5份；
③称取山茶(CAMELLIA JAPONICA)籽油30份、甜扁桃(PRUNUS AMYGDALUS DULCIS)油10份、深海两节荠(CRAMBE ABYSSINICA)籽油3.6份、亚麻荠(CAMELINA SATIVA)籽油2.5份、玻璃苣(BORAGO OFFICINALIS)籽油2.5份、向日葵(HELIANTHUS ANNUUS)籽油1份、油橄榄(OLEA EUROPAEA)果油1份、猴面包树(ADANSONIA DIGITATA)籽油1份、海檀木(XIMENIAAMERICANA)籽油1份、岩兰草(VETIVERIA ZIZANIOIDES)根油0.1份、檀香(SANTALUM ALBUM)油0.1份、茉莉花(JASMINUM SAMBAC)花油0.1份、香柠檬(CITRUS AURANTIUM BERGAMIA)果油0.1份、玫瑰(ROSA RUGOSA)花油0.03份、母菊(CHAMOMILLA RECUTITA)花油0.01份、沙棘(HIPPOPHAE RHAMNOIDES)果油0.025份、角鲨烷33份、辛酸/癸酸甘油三酯10.34份、红没药醇0.2份和生育酚1份；
④将称取好的山茶(CAMELLIA JAPONICA)籽油30份、甜扁桃(PRUNUSAMYGDALUSDULCIS)油10份、深海两节荠(CRAMBE ABYSSINICA)籽油3.6份、亚麻荠(CAMELINASATIVA)籽油2.5份、玻璃苣(BORAGO OFFICINALIS)籽油2.5份、向日葵(HELIANTHUSANNUUS)籽油1份、油橄榄(OLEA EUROPAEA)果油1份、猴面包树(ADANSONIA DIGITATA)籽油1份、海檀木(XIMENIA AMERICANA)籽油1份、岩兰草(VETIVERIA ZIZANIOIDES)根油0.1份、檀香(SANTALUM ALBUM)油0.1份、茉莉花(JASMINUM SAMBAC)花油0.1份、香柠檬(CITRUSAURANTIUM BERGAMIA)果油0.1份、玫瑰(ROSA RUGOSA)花油0.03份、母菊(CHAMOMILLARECUTITA)花油0.01份、沙棘(HIPPOPHAE RHAMNOIDES)果油0.025份、角鲨烷33份、辛酸/癸酸甘油三酯10.34份、红没药醇0.2份、生育酚1份与搅拌好的复合奇亚籽油2.5份，导入乳化锅中搅拌均匀；
⑤静置12小时，罐装。
实验例5.皮肤屏障修复功效测试
测试人群为10名脸部泛红的志愿者，每5人一组，共分为2组测试对象，分别使用本发明实施例五的产品以及某市售复方保湿修复精油。
测试区域：全脸；
使用：每天早晚使用两次。使用德国CK公司TM300测试仪分别测试第0周和持续使用至第4周、第8周后脸颊部位的经皮水份流失，简称TEWL(g/㎡h)，即每小时每平方米面积散失多少克水。皮肤水份流失TEWL对评估皮肤水份保护层的功能是非常重要的参数，在国际上已经得到了广泛的认可，可以很好的反应皮肤屏障功能的完整性。标准的TEWL是在皮肤干燥无汗状态下，在环境温度24℃，环境湿度为50％的状态下测量的。
评价标准：皮肤保护层越完好，水份的含量就会越高，皮肤水份流失的TEWL的数值就越低，即皮肤屏障得到修复，结果见图3。
从以上数据可以看出，实施例五的产品与复方保湿修复精油相比，在使用一段时间后均能降低经皮水分散失值(TEWL)，说明修复皮肤屏障效果明显。
以上内容是结合具体的优选实施方式对本发明所作的进一步详细说明，不能认定本发明的具体实施只局限于这些说明。对于本发明所属技术领域的普通技术人员来说，在不脱离本发明构思的前提下，还可以做出若干简单推演或替换，都应当视为属于本发明的保护范围。
Claims (10)
1.一种植物复方精油组合物，其特征在于，所述植物复方精油组合物包含以下成分：
其中，所述复合奇亚籽油由西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂组成；
所述抗氧化剂选自生育酚、生育酚乙酸酯、生育酚磷酸酯、四己基癸醇抗坏血酸酯或虾青素中的一种或多种；
所述西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂的质量比为(99.9:0.1)～(99.99:0.01)；
所述复合微量精油包含以下成分：
2.根据权利要求1所述的植物复方精油组合物，其特征在于，所述植物复方精油组合物包含以下成分：
其中，所述复合奇亚籽油由西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂组成；
所述抗氧化剂选自生育酚、生育酚乙酸酯、生育酚磷酸酯、四己基癸醇抗坏血酸酯或虾青素中的任一种；
所述西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂的质量比为(99.93:0.07)～(99.97:0.03)；
所述复合微量精油包含以下成分：
3.根据权利要求1或2所述的植物复方精油组合物，其特征在于，所述植物复方精油组合物由以下成分组成：
其中，所述复合奇亚籽油由西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂组成；
所述抗氧化剂选自生育酚、生育酚乙酸酯或生育酚磷酸酯中的任一种；
所述西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂的质量比为99.95:0.05；
所述复合微量精油由以下成分组成：
4.一种保湿修复化妆品组合物，其特征在于，所述保湿修复化妆品组合物，包含以下成分：
权利要求1-3任一项所述的植物复方精油组合物50-60份油性溶剂35-50份
皮肤调理剂0.5-2份；
其中，所述油性溶剂选自椰子油、角鲨烷、辛酸/癸酸甘油三酯或碳酸二辛酯中的一种或多种；所述皮肤调理剂选自红没药醇、熊果苷、烟酰胺、甘草酸二钾或生育酚中的一种或多种。
5.根据权利要求4所述的保湿修复化妆品组合物，其特征在于，所述保湿修复化妆品组合物，由以下成分组成：
权利要求1-3任一项所述的植物复方精油组合物50-60份油性溶剂35-50份
皮肤调理剂0.5-2份；
其中，所述油性溶剂为角鲨烷和辛酸/癸酸甘油三酯，所述角鲨烷和辛酸/癸酸甘油三酯的质量比为(30:10)～(35:12)；所述皮肤调理剂为红没药醇和生育酚，所述红没药醇和生育酚的质量比为(0.08:0.5)～(0.25:1)。
6.根据权利要求4或5所述的保湿修复化妆品组合物，其特征在于，所述保湿修复化妆品组合物，由以下成分组成：
其中，所述复合奇亚籽油由西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚组成；所述西班牙鼠尾草(SALVIA HISPANICA)籽油和抗氧化剂的质量比为99.95:0.05；所述复合微量精油由以下成分组成：
7.根据权利要求4-6任一项所述的保湿修复化妆品组合物，其特征在于，所述保湿修复化妆品组合物，由以下成分组成：
8.权利要求4-7任一项所述的保湿修复化妆品组合物的制备方法，其特征在于，采用如下方法制备：
①按照权利要求4-7任一项所述的保湿修复化妆品组合物的原料配比，称取组成复合奇亚籽油的西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚；
②将称取好的西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚导入乳化锅中搅拌均匀，制得复合奇亚籽油；
③按照权利要求4-7任一项所述的保湿修复化妆品组合物的原料配比，称取剩余原料；
④将称取好的剩余原料与制备好的复合奇亚籽油，导入乳化锅中搅拌均匀；
⑤静置12小时，罐装。
9.根据权利要求8所述的保湿修复化妆品组合物的制备方法，其特征在于，采用如下方法制备：
①称取西班牙鼠尾草(SALVIA HISPANICA)籽油2.49875份和生育酚0.00125份；
②将西班牙鼠尾草(SALVIA HISPANICA)籽油和生育酚导入乳化锅中搅拌均匀，制得复合奇亚籽油2.5份；
③称取山茶(CAMELLIA JAPONICA)籽油30份、甜扁桃(PRUNUS AMYGDALUS DULCIS)油10份、深海两节荠(CRAMBE ABYSSINICA)籽油3.6份、亚麻荠(CAMELINA SATIVA)籽油2.5份、玻璃苣(BORAGO OFFICINALIS)籽油2.5份、向日葵(HELIANTHUS ANNUUS)籽油1份、油橄榄(OLEA EUROPAEA)果油1份、猴面包树(ADANSONIA DIGITATA)籽油1份、海檀木(XIMENIAAMERICANA)籽油1份、岩兰草(VETIVERIA ZIZANIOIDES)根油0.1份、檀香(SANTALUM ALBUM)油0.1份、茉莉花(JASMINUM SAMBAC)花油0.1份、香柠檬(CITRUS AURANTIUM BERGAMIA)果油0.1份、玫瑰(ROSA RUGOSA)花油0.03份、母菊(CHAMOMILLA RECUTITA)花油0.01份、沙棘(HIPPOPHAE RHAMNOIDES)果油0.025份、角鲨烷33份、辛酸/癸酸甘油三酯10.34份、红没药醇0.2份和生育酚1份；
④将称取好的山茶(CAMELLIA JAPONICA)籽油30份、甜扁桃(PRUNUSAMYGDALUSDULCIS)油10份、深海两节荠(CRAMBE ABYSSINICA)籽油3.6份、亚麻荠(CAMELINASATIVA)籽油2.5份、玻璃苣(BORAGO OFFICINALIS)籽油2.5份、向日葵(HELIANTHUSANNUUS)籽油1份、油橄榄(OLEA EUROPAEA)果油1份、猴面包树(ADANSONIA DIGITATA)籽油1份、海檀木(XIMENIA AMERICANA)籽油1份、岩兰草(VETIVERIA ZIZANIOIDES)根油0.1份、檀香(SANTALUM ALBUM)油0.1份、茉莉花(JASMINUM SAMBAC)花油0.1份、香柠檬(CITRUSAURANTIUM BERGAMIA)果油0.1份、玫瑰(ROSA RUGOSA)花油0.03份、母菊(CHAMOMILLARECUTITA)花油0.01份、沙棘(HIPPOPHAE RHAMNOIDES)果油0.025份、角鲨烷33份、辛酸/癸酸甘油三酯10.34份、红没药醇0.2份、生育酚1份与搅拌好的复合奇亚籽油2.5份，导入乳化锅中搅拌均匀；
⑤静置12小时，罐装。
10.权利要求1-3任一项所述的植物复方精油组合物、或权利要求4-7任一项所述的保湿修复化妆品组合物、或权利要求8或9所述的制备方法制得的保湿修复化妆品组合物在制备具有保湿、修复功效的化妆品中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410136572.6A CN118045010B (zh) | 2024-01-31 | 2024-01-31 | 一种含有植物复方精油组合物的保湿修复精华油及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410136572.6A CN118045010B (zh) | 2024-01-31 | 2024-01-31 | 一种含有植物复方精油组合物的保湿修复精华油及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN118045010A true CN118045010A (zh) | 2024-05-17 |
| CN118045010B CN118045010B (zh) | 2024-08-30 |
Family
ID=91046155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410136572.6A Active CN118045010B (zh) | 2024-01-31 | 2024-01-31 | 一种含有植物复方精油组合物的保湿修复精华油及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118045010B (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021218039A1 (zh) * | 2020-04-29 | 2021-11-04 | 上海林清轩生物科技有限公司 | 一种仿生的、含山茶提取物的修复皮肤屏障组合物和应用 |
| CN114028277A (zh) * | 2021-12-22 | 2022-02-11 | 广州阳菲生物科技有限公司 | 一种具有舒缓修复敏感肌肤的安肤膏 |
| CN117159412A (zh) * | 2023-07-04 | 2023-12-05 | 伊殿品牌香港有限公司 | 一种外用植物源的仿生胎脂护肤组合物及应用和制备方法 |
-
2024
- 2024-01-31 CN CN202410136572.6A patent/CN118045010B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021218039A1 (zh) * | 2020-04-29 | 2021-11-04 | 上海林清轩生物科技有限公司 | 一种仿生的、含山茶提取物的修复皮肤屏障组合物和应用 |
| CN114028277A (zh) * | 2021-12-22 | 2022-02-11 | 广州阳菲生物科技有限公司 | 一种具有舒缓修复敏感肌肤的安肤膏 |
| CN117159412A (zh) * | 2023-07-04 | 2023-12-05 | 伊殿品牌香港有限公司 | 一种外用植物源的仿生胎脂护肤组合物及应用和制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| N: "holistic green beauty PINK LOTUS CELLULAR REPAIR OIL", Retrieved from the Internet <URL:https://www.cosdna.com/chs/cosmetic_0b62534814.html> * |
| 新丝美生物科技: "植物精萃面部精华油", Retrieved from the Internet <URL:https://mp.weixin.qq.com/s/z_hOEyhHx9gia5MosQoA6A> * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN118045010B (zh) | 2024-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2383448T3 (es) | Composición cosmética para luchar contra las consecuencias cutáneas de la polución | |
| CN108653093B (zh) | 一种具有美白亮肤功效的化妆品组合物 | |
| KR101972071B1 (ko) | 피부톤 개선 또는 피부 탄력 증진용 화장료 조성물 | |
| EP3380201B1 (en) | Anti-pollution complex comprising oily and aqueous calendula extracts and an aqueous extract of lilium candidum bulb and uses thereof | |
| CN113712862A (zh) | 一种具有延缓皮肤衰老作用的植物油组合物及其应用 | |
| CN103330658A (zh) | 具有修复受损皮脂膜、舒缓皮肤压力的护肤组合物 | |
| CN115154383A (zh) | 一种温和美白组合物及其美白面霜 | |
| US10022415B2 (en) | External composition for skin containing an enzyme-treated saponin fraction derived from the root of Camellia sinensis | |
| US20180140537A1 (en) | Active complex for a cosmetic product against skin ageing | |
| CN118045010B (zh) | 一种含有植物复方精油组合物的保湿修复精华油及其制备方法 | |
| US5409702A (en) | Cosmetics | |
| CN110227050B (zh) | 一种抗衰老修护缓释精华液及采用其制备的抗衰老修护面膜 | |
| KR20110007751A (ko) | 화장품의 ｐＨ범위가 약산성으로 변하는 것을 화장품 색의 변화로 알 수 있게 하는 2제형 화장품 조성물 및 이를 이용한 화장품 | |
| CN114983841B (zh) | 一种不含硅油的油包水牡丹防晒乳及其制备方法 | |
| CN108904387A (zh) | 一种对抗外源压力、保护dna的护肤基质及其制备方法和应用 | |
| CN115177565A (zh) | 一种美白亮肤组合物及其在化妆品中的应用 | |
| CN115350125A (zh) | 一种含植物芽提取物的温和无刺激多功效组合物、护肤产品及其制备方法和应用 | |
| Sadsyam et al. | Antioxidant evaluation of facial toner formulations containing ethyl acetate fraction from Garcinia mangostana L. Fruit using ABTS 2, 2'-azinobis 3-ethyl benzothiazoline 6-sulphonic acid method | |
| CN117482020B (zh) | 一种修护皮肤屏障的组合物及其制备方法与应用 | |
| Al-Rimawi et al. | Formulation and evaluation of a moisturizing day cream containing olive leaves extract | |
| Harvell et al. | An in vivo correlation with three in vitro assays to assess skin irritation potential | |
| Supriadi et al. | Formulation and Evaluation of Grape Seed Oil (Vitis Vinifera, L) Facial Cream with Variations in The Concentration of Stearic Acid as an Emulsifier | |
| CN117860638B (zh) | 一种含有玻色因的修护抗衰组合物的制备方法和应用 | |
| CN109199927A (zh) | 一种添加植物油的防晒霜及其制备方法 | |
| CN114848532B (zh) | 一种化妆品用的富含生物素和鸟苷的组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |